Use of EphrinB2 directed agents for the treatment or prevention of viral infections

Details for Australian Patent Application No. 2006294873 (hide)

Owner Vasgene Therapeutics, Inc.

Inventors Gill, Parkash; Krasnoperov, Valery

Agent Shelston IP

Pub. Number AU-A-2006294873

PCT Pub. Number WO2007/038395

Priority 60/719,942 23.09.05 US

Filing date 25 September 2006

Wipo publication date 5 April 2007

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/038395 Priority application(s): WO2007/038395

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006294878-Ophthalmic lens package with a deformable bottom and methods of its use

2006294870-Antibodies with simultaneous subsite specificities to protein and lipid epitopes